# The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2024

S.I. 2024/1334 · made 11 December 2024

These Regulations amend assimilated law, Regulation (EC) No 1223/2009 (“the Regulation”), to prohibit or restrict the use of certain substances in cosmetic products.

PDFs: Printed copy https://openlegislation.uk/cosmetic-products-restriction-of-chemical-substances-no-2-regulations-2024/pdf/uksi_20241334_en.pdf; UK Explanatory Memorandum https://openlegislation.uk/cosmetic-products-restriction-of-chemical-substances-no-2-regulations-2024/pdf/uksiem_20241334_en_001.pdf

## Introductory text

CONSUMER PROTECTION
Made 11th December 2024
Laid before Parliament 17th December 2024
Coming into force 31st January 2025
The Secretary of State makes these Regulations in exercise of the powers conferred by Articles 31(1)(b), 31(1)(f) and 32(1)(b) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (“the Regulation”).
In accordance with Article 31(1)(b) of the Regulation, the Secretary of State considers there is sufficient scientific evidence that there is a potential risk to human health arising from the use, in cosmetic products, of the substance set out in Schedule 2 to these Regulations.
In accordance with Article 31(1)(f) of the Regulation, the substances set out in Schedule 1 to these Regulations have been classified as CMR substances of category 1A, 1B or 2 under Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures.

## 1 Citation, commencement and extent

(1) These Regulations may be cited as the Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2024 and come into force on 31st January 2025.
(2) These Regulations extend to England and Wales and Scotland.

## 2 Amendment to Regulation (EC) No 1223/2009

(1) Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products is amended as follows.
(2) At the end of the table in Annex 2 (list of substances prohibited in cosmetic products), insert the entries set out in Schedule 1 to these Regulations.
(3) At the end of the table in Annex 3 (list of substances which cosmetic products must not contain except subject to the restrictions laid down), insert the entries set out in Schedule 2 to these Regulations.

## 3 Transitional Provisions

(1) Notwithstanding the amendments in regulation 2(2), cosmetic products containing any of the substances set out in Schedule 1 to these Regulations at reference numbers 1680 to 1730 that are placed on the market on or before 20th April 2025 may continue to be made available on the market on or before 20th October 2025.
(2) Notwithstanding the amendments in regulation 2(2), cosmetic products containing any of the substances set out in Schedule 1 to these Regulations at reference numbers 1731 to 1743 that are placed on the market on or before 2nd September 2025 may continue to be made available on the market on or before 2nd March 2026.
(3) Notwithstanding the amendment in regulation 2(3), cosmetic products that are placed on the market on or before 20th June 2025 may continue to be made available on the market on or before 1st November 2025.

## Signature

Justin Madders
Parliamentary Under-Secretary of State
Department for Business and Trade
11th December 2024

## Schedule 1 Amendments to Annex 2

1680
Tetrafluoroethylene
116-14-3
204-126-9
1681
6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol; [DBMC]
119-47-1
204-327-1
1682
(5-chloro-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone
688046-61-9
692-456-8
1683
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate
1101132-67-5
1684
3-methylpyrazole
1453-58-3
215-925-7
1685
N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide; Pydiflumetofen
1228284-64-7
1686
N-{2-[[1,1'-bi(cyclopropyl)]-2-yl]phenyl}- 3-(difluoromethyl)-1-methyl-1Hpyrazole-4-carboxamide; Sedaxane
874967-67-6
1687
Thiophanate-methyl (ISO); dimethyl (1,2- phenylenedicarbamothioyl)biscarbamat; dimethyl 4,4’-(o-phenylene)bis(3- thioallophanate)
23564-05-8
245-740-7
1688
Mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt
8018-01-7
1689
Trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2]
12035-72-2 [1] 12035-71-1 [2]
234-829-6 [1] – [2]
1690
7-oxa-3-oxiranylbicyclo[4.1.0]heptane; 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide
106-87-6
203-437-7
1691
4-methylpentan-2-one; isobutyl methyl ketone (MIBK)
108-10-1
203-550-1
1692
Carbendazim (ISO); methyl benzimidazole-2-ylcarbamat
10605-21-7
234-232-0
1693
Dimethomorph (ISO); (E,Z)-4-(3-(4- chlorophenyl)-3-(3,4- dimethoxyphenyl)acryloyl)morpholine
110488-70-5; (1135441-72-3)
404-200-2
1694
1,2,4-triazole
288-88-0
206-022-9
1695
Flumioxazin (ISO); N-(7-fluoro-3,4- dihydro-3-oxo-4-prop-2-ynyl-2H-1,4- benzoxazin-6-yl)cyclohex-1-ene-1,2- dicarboximide
103361-09-7
1696
Imazamox (ISO); (RS)-2-(4-isopropyl-4- methyl- 5-oxo-2-imidazolin-2-yl)-5- methoxymethylnicotinic acid
114311-32-9
1697
Thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5- methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine
153719-23-4
428-650-4
1698
Triticonazole (ISO); (RS)-(E)-5-(4- chlorobenzylidene)-2,2-dimethyl-1-(1H1,2,4-triazol-1-ylmethyl)cyclopentanol
138182-18-0
1699
Desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate
13684-56-5
237-198-5
1700
Tellurium dioxide
7446-07-3
231-193-1
1701
Tellurium
13494-80-9
236-813-4
1702
Fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5- (trifluoromethyl)-2- pyridylmethyl]benzamide
239110-15-7
607-285-6
1703
Daminozide (ISO); 4-(2,2- dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid
1596-84-5
216-485-9
1704
Benzophenone
119-61-9
204-337-6
1705
Acetamiprid (ISO); (1E)-N-[(6- chloropyridin-3- yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N 1 -[(6- chloro-3-pyridyl)methyl]-N 2 -cyano-N 1 – methylacetamidine
135410-20-7
603-921-1
1706
Theophylline; 1,3-dimethyl-3,7-dihydro-1 H-purine-2,6-dione
58-55-9
200-385-7
1707
N-(2-nitrophenyl)phosphoric triamide
874819-71-3
477-690-9
1708
Dibutyltin di(acetate)
1067-33-0
213-928-8
1709
Dibutyltin bis(2-ethylhexanoate)
2781-10-4
220-481-2
1710
Cumene
98-82-8
202-704-5
1711
Barium diboron tetraoxide
13701-59-2
237-222-4
1712
2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3- propanediyldiacrylate; 2,2- bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate
15625-89-5
239-701-3
1713
Quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone
2797-51-5
220-529-2
1714
Pendimethalin (ISO); N-(1-ethylpropyl)- 2,6-dinitro-3,4-xylidene
40487-42-1
254-938-2
1715
Isoflucypram (ISO); N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide
1255734-28-1
1716
Dimoxystrobin (ISO); (2E)-2-{2-[(2,5- dimethylphenoxy)methyl]phenyl}-2- (methoxyimino)-N-methylacetamide; (E)-2- (methoxyimino)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl]acetamide
149961-52-4
604-712-8
1717
2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2- bis(bromomethyl)propan-1-ol
36483-57-5; 1522-92-5
253-057-0
1718
2,4,6-tri-tert-butylphenol
732-26-3
211-989-5
1719
Ammonium bromide
12124-97-9
235-183-8
1720
Divanadium pentaoxide; Vanadium pentoxide
1314-62-1
215-239-8
1721
Bentazone (ISO); 3-isopropyl-2,1,3- benzothiadiazine-4-one-2,2-dioxide
25057-89-0
246-585-8
1722
Margosa extract. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents]
84696-25-3
283-644-7
1723
Valifenalate (ISO); methyl N-(isopropoxycarbonyl)-L-valyl- (3RS)-3- (4-chlorophenyl)-β-alaninate
283159-90-0
1724
Isopyrazam (ISO); reaction mass of 3-(difluoromethyl)-1-methyl-N- [(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4- methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4- tetrahydro-9-isopropyl-1,4-methanonaphthalen-5- yl]pyrazole-4-carboxamide [>78% syn isomers ≤ 15% anti isomers relative content];
881685-58-1
1725
Perfluoroheptanoic acid; tridecafluoroheptanoic acid
375-85-9
206-798-9
1726
4,4’-sulphonyldiphenol; bisphenol S
80-09-1
201-250-5
1727
6-[C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid (tetra-PSCA)
2156592-54-8
701-118-1
1728
6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid (Penta-PSCA)
701-162-1
1729
[C12-18-alkyl-(branched, unsaturated)- 2,5-dioxopyrrolidin-1-yl] hexanoic acid, sodium and tris(2-hydroxyethyl) ammonium salts; (penta-PSCA Na-TEA)
701-271-4
1730
1,3,5-triazine-2,4,6-triamine; melamine
108-78-1
203-615-4
1731
Benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate
577705-90-9
479-100-5
1732
Benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1)
75768-65-9
278-305-5
1733
Reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate (1:1)
1734
Reaction mass of 4,4'-[2,2,2-trifluoro 1-(trifluoromethyl)ethylidene] diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1- (trifluoromethyl)ethylidene]bis[phenol] (1:1)
1735
Reaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2- ((2,3-epoxypropoxy)methyl) -2-hydroxymethyl butane
1736
4,4'-[2,2,2-trifluoro-1- (trifluoromethyl)ethylidene]diphenol; bisphenol AF
1478-61-1
216-036-7
1737
Transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate
118712-89-3
405-060-5
1738
Salts of 2-ethylhexanoic acid
1739
Benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine
1861-40-1
217-465-2
1740
N,N-dimethyl-p-toluidine
99-97-8
202-805-4
1741
4-nitrosomorpholine
59-89-2
1742
3,3'-dimethylbiphenyl 4,4'-diyl diisocyanate
91-97-4
202-112-7
1743
Foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea
173159-57-4

## Schedule 2 Amendment to Annex 3

323
5-hydroxy-2-(hydroxymethyl)pyran-4-one
Kojic acid
501-30-4
207-922-4
Face and hand products
1%

## Explanatory note

(This note is not part of the Regulations)
These Regulations amend assimilated law, Regulation (EC) No 1223/2009 (“the Regulation”), to prohibit or restrict the use of certain substances in cosmetic products.
Regulation 2(2) amends Annex 2 to the Regulation to prohibit the use of certain substances in cosmetic products following their classification as category 1A, 1B or 2 carcinogenic, mutagenic or toxic for reproduction substances under assimilated Regulation (EC) No 1272/2008.
Regulation 2(3) amends Annex 3 to the Regulation to restrict the use of kojic acid in cosmetic products following advice from the Scientific Advisory Group on Chemical Safety of Non-Food and Non-Medicinal Consumer Products that there is a potential risk to human health from its use.
Regulation 3 sets out the transitional arrangements for cosmetic products containing the substances listed in the Schedules to these Regulations.
A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or business sectors is foreseen. An Explanatory Memorandum is published alongside these Regulations on www.legislation.gov.uk.

---
Source: https://www.legislation.gov.uk/uksi/2024/1334 (the official version)
Page: https://openlegislation.uk/cosmetic-products-restriction-of-chemical-substances-no-2-regulations-2024
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.